Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A Prospective, First in Human Study to Evaluate the Safety and Performance of a Flow Modification System
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Treating Patients with ED | Other | Treatment of patients with ED |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ED surgery | Device | The surgical implant for ED treatment |
|
| Measure | Description | Time Frame |
|---|---|---|
| The surgical implant for ED treatment | Primary Safety Endpoint • 30-day Freedom from Major Adverse Events | 12 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
- 1. Current participation in any clinical study with any investigational drug or device.
2. Patient is known or suspected not to tolerate the procedure, including exposure to contrast 3. Active infection or fever that may be due to infection 4. Life expectancy < 2 years due to other illnesses
male
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007172 | Erectile Dysfunction |
| ID | Term |
|---|---|
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D012735 | Sexual Dysfunction, Physiological |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D052801 | Male Urogenital Diseases |
| D020018 | Sexual Dysfunctions, Psychological |
| D001523 | Mental Disorders |